1Benavides J,Schoemaker H,Dana C,et al.In vivo and interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1receptors in the rodent[J].Arzneimitteforschung,1995,45:551～558.
2Pichat P,Angel I,Arbilla S.Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat[J].Arzneimittelforschung,1998,48:173～178.
2Pichat P;Angel I;Arbilla S.Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat,1998(01).
3Benavides J;Schoemaker H;Dana C.In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent,1995.
4Dubertr;Murrieta Aguttes M;Tonet J.Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria:results of the MILOR Study[J],1999.
5Sabbah A;Daele J;Wade AG.Comparison of the efficacy,safety,and onset of action of mizolastine,cetirizine,and placebo in the management of seasonal allergic rhinoconjunctivitis.MIZOCET Study Group[J],1999.
6Leynadier F;Duarte-Risselin C;Murrieta M.Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria URTILOR study group,2000.
5Bachert C, Maurer M. Safety and efficacy of deslorata- dine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance stud- ies [J]. Clin Drug Investig , 2010,30 ( 2 ) : 109.
6Paul E, Bodeker RH. Treatment of chronic urticaria with terfenadine and ranitidine: a randomized double-blind stu- dy in 45 patients[J]. Eur J Clin Pharmacol, 1986,31 (3) : 277.
7Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/ GA (2) LEN/EDF/WAO guideline: definition, classifica- tion and diagnosis of urticaria[J]. Allergy, 2009,64 ( 10 ) : 1 417.
8Benavides J, Schoemaker H, Dana C, et al. In vivo and in vitro interaction of the novel selective histamine H1 re- ceptor antagonist mizolastine with Hi receptors in the ro- dent[J]. Arzneimittelforschung, 1995,45 (5) : 551.
9Begg CB, Mazumdar M. Operating characteristics of a ra- nk correlation test for publication bias[J]. Biometrics, 1994,50(4) : 1 088.
10Martinez C, Albet C, Agundez JA, et al. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1 A2, CYP2D6, and CYP3A by H2-receptor antagonists[J]. Clin Pharmacol Ther , 1999,65 (4) :369.
